PharmaReports: Immunology & Inflammatory Diseases
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
Reports relating to inflammatory diseases and organ transplant are featured in this channel. Articles on osteoarthritis are also featured here. Reports focusing on immunological approaches to other disease states can also be included in this channel.
Showing results 51 - 100 of 157
- Pipeline Insight Asthma/COPD/Allergic Rhinitis - As Patents Expire, Novel Combinations Inspire
- Psoriasis - Biologics Impact Treatment Regimes Across the Globe
- Stakeholder Insight: Asthma - Combination Therapy Appropriate for Everyone?
- Systemic Lupus Erythematosus - On the Verge of a Breakthough
- Immunotherapy in Allergic Rhinitis
- Kidney Transplantation - Switching to calcineurin inhibitor-free immunosuppression
- Monoclonal Antibodies: Financial and strategic analysis of the mAb market
- Multiple Sclerosis - Continued growth makes the MS market a highly attractive investment
- Drug Discovery Tools for High-Content Analysis
- Commercial Insight: Asthma & COPD - Combination products still have blockbuster potential
- ALLERGY - Therapy Area Pipeline Report
- ARTHRITIS - Therapy Area Pipeline Report
- AUTOIMMUNE DISEASES - Therapy Area Pipeline Report
- CROHN DISEASE - Therapy Area Pipeline Report
- INFLAMMATION - Therapy Area Pipeline Report
- LUPUS - Therapy Area Pipeline Report
- RHEUMATOID ARTHRITIS - Therapy Area Pipeline Report
- ORGAN TRANSPLANTATION - Therapy Area Pipeline Report
- MULTIPLE SCLEROSIS - Therapy Area Pipeline Report
- ECZEMA - Therapy Area Pipeline Report
- ULCERATIVE COLITIS - Therapy Area Pipeline Report
- TYPE 1 DIABETES - Therapy Area Pipeline Report
- OSTEOARTHRITIS - Therapy Area Pipeline Report
- OCULAR INFLAMMATION - Therapy Area Pipeline Report
- ASTHMA - Therapy Area Pipeline Report
- BRONCHITIS - Therapy Area Pipeline Report
- BRONCHOSPASM - Therapy Area Pipeline Report
- CHRONIC OBSTRUCTIVE PULMONARY DISEASE - Therapy Area Pipeline Report
- COUGH - Therapy Area Pipeline Report
- NASAL CONGESTION - Therapy Area Pipeline Report
- GINGIVITIS and PERIODONTITIS - Therapy Area Pipeline Report
- Autoimmune Market Outlook to 2012
- Monoclonal Antibodies: strategic analysis of the mAb market out to 2012
- The Future of Biosimilars: Key opportunities & emerging therapies
- Top Companies and Products in the RNA/DNA Therapy Products Market
- Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family
- Commercial and Pipeline Insight: Allergic Rhinitis
- Biosimilars Series: Strategic issues - Potential remains uncertain
- Immunomodulators: Therapeutic Needs, Pipelines and Prospects
- Translational Medicine in Biopharmaceutical Research and Development
- Multiple Sclerosis Market Analysis and Forecasts Report 2007-2022
- The Gastrointestinal Market Outlook to 2012
- Licensing Strategies - Current Pharmaceutical Licensing Trends
- Pediatric Drugs - the Worldwide Market
- Autoimmune Disorders and Transplant Rejection - The Potential of T-cells Targeted Therapeutics
- Rheumatoid arthritis - Emerging drug discovery targets and therapeutic candidates
- Asthma Therapeutics - New treatment options and emerging drug discovery targets
- BAFF (BLys) and APRIL: Emerging Targets for autoimmune disease & Cancer Therapeutics
- Coxibs - Past Problems and Future Potential
- Disease Modifying Osteoarthritis Drugs - The Search for the Holy Grail Continues
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development